MARKET

CNSP

CNSP

CNS PHARMACEUTICALS, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.400
-0.050
-1.12%
Closed 16:00 01/24 EST
OPEN
4.460
PREV CLOSE
4.450
HIGH
4.500
LOW
4.390
VOLUME
34.00K
TURNOVER
--
52 WEEK HIGH
5.69
52 WEEK LOW
3.650
MARKET CAP
69.13M
P/E (TTM)
-13.9196
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CNSP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CNSP News

  • CNS Pharmaceuticals Announces Contract With International GMP Manufacturer For Production Of Berubicin
  • Benzinga.01/14 13:05
  • CNS Pharmaceuticals Announces Contract with International GMP Manufacturer for Production of Berubicin
  • PR Newswire.01/14 13:00
  • CNS Pharmaceuticals Licenses Breakthrough Technology from MD Anderson, Doubling its Drug Pipeline
  • PR Newswire.01/13 13:00
  • CNS Pharmaceuticals Partnered with Anthem Biosciences Pvt. Ltd. in Preparation for Upcoming Proposed Phase 2 Clinical Trial
  • PR Newswire.12/17/2019 13:00

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About CNSP

CNS Pharmaceuticals Inc. is a preclinical stage pharmaceutical company. The Company is focused on developing anticancer drug candidates for the treatment of brain and central nervous system tumors. The Company is focused on developing its lead drug candidate, Berubicin for the treatment of glioblastoma. Glioblastoma are tumors that arise from astrocytes, which are star-shaped cells making up the supportive tissue of the brain. Berubicin is an anthracycline, a class of drugs that are among the chemotherapy drugs, which intercalates into Deoxyribonucleic acid (DNA) and interrupts topoisomerase II activity. It results in the inhibition of DNA replication and repair, and Ribonucleic acid (RNA) and protein synthesis.
More

Webull offers CNS Pharmaceuticals Inc (CNSP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.